108 related articles for article (PubMed ID: 25626421)
21. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
22. [The relationship with human papilloma virus DNA in cervical adenocarcinoma].
Ogura K; Ishi K; Suzuki F; Suto H; Kina K; Koyatsu J; Nojima M; Yoshida K; Suda K
Rinsho Byori; 2004 Feb; 52(2):115-9. PubMed ID: 15027314
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas.
Ogura K; Ishi K; Matsumoto T; Kina K; Nojima M; Suda K
Pathol Int; 2006 Jun; 56(6):301-8. PubMed ID: 16704493
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus detection in adenocarcinoma and adenosquamous carcinoma of the uterine cervix in Taiwan.
Tseng HH; Wang JS; Kan YY
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):47-53. PubMed ID: 8820036
[TBL] [Abstract][Full Text] [Related]
26. The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas.
Andersson S; Rylander E; Strand A; Sällström J; Wilander E
Br J Cancer; 2001 Oct; 85(8):1153-6. PubMed ID: 11710828
[TBL] [Abstract][Full Text] [Related]
27. Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior.
Hodgson A; Howitt BE; Park KJ; Lindeman N; Nucci MR; Parra-Herran C
Int J Gynecol Pathol; 2020 Nov; 39(6):578-586. PubMed ID: 31855952
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus type distribution in cervical cancer in Delhi, India.
Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE
Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719
[TBL] [Abstract][Full Text] [Related]
29. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
30. Human papilloma virus genotypes in Ghanaian women with cervical carcinoma.
Attoh S; Asmah R; Wiredu EK; Gyasi R; Tettey Y
East Afr Med J; 2010 Aug; 87(8):345-9. PubMed ID: 23451558
[TBL] [Abstract][Full Text] [Related]
31. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
[TBL] [Abstract][Full Text] [Related]
32. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.
Sasagawa T; Basha W; Yamazaki H; Inoue M
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):45-52. PubMed ID: 11205488
[TBL] [Abstract][Full Text] [Related]
33. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
34. Unique microRNA expression profiles in cervical cancer.
Gocze K; Gombos K; Juhasz K; Kovacs K; Kajtar B; Benczik M; Gocze P; Patczai B; Arany I; Ember I
Anticancer Res; 2013 Jun; 33(6):2561-7. PubMed ID: 23749909
[TBL] [Abstract][Full Text] [Related]
35. Cytomegalovirus and cervical cancer: failure to detect a direct association or an interaction with human papillomaviruses.
Thompson CH; Rose BR; Elliott PM
Gynecol Oncol; 1994 Jul; 54(1):40-6. PubMed ID: 8020838
[TBL] [Abstract][Full Text] [Related]
36. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
37. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
Zhao C; Li Z; Austin RM
Am J Clin Pathol; 2013 Jul; 140(1):47-54. PubMed ID: 23765533
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries.
De Boer MA; Peters LA; Aziz MF; Siregar B; Cornain S; Vrede MA; Jordanova ES; Fleuren GJ
Int J Cancer; 2005 Apr; 114(3):422-5. PubMed ID: 15551313
[TBL] [Abstract][Full Text] [Related]
39. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix.
Wilting SM; Snijders PJ; Meijer GA; Ylstra B; van den Ijssel PR; Snijders AM; Albertson DG; Coffa J; Schouten JP; van de Wiel MA; Meijer CJ; Steenbergen RD
J Pathol; 2006 Jun; 209(2):220-30. PubMed ID: 16538612
[TBL] [Abstract][Full Text] [Related]
40. Liquid biopsy of PIK3CA mutations in cervical cancer in Hong Kong Chinese women.
Chung TKH; Cheung TH; Yim SF; Yu MY; Chiu RWK; Lo KWK; Lee IPC; Wong RRY; Lau KKM; Wang VW; Worley MJ; Elias KM; Fiascone SJ; Smith DI; Berkowitz RS; Wong YF
Gynecol Oncol; 2017 Aug; 146(2):334-339. PubMed ID: 28587748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
